All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Conditioning regimens prior to allo-HSCT: Updates from the 48th Annual Meeting of the EBMT (2022)
At the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the safety and efficacy of conditioning combinations...
How are new fludarabine conditioning combinations impacting transplant outcomes?
Gavriilaki begins by discussing a study presented at EBMT 2022 that explored outcomes of fludarabine + treosulfan, which followed on from previous studies exploring...
"The AML Hub is a trusted, respected, and comprehensive resource where clinicians and researchers interested in AML can confidently learn about the most exciting and novel clinical and biological advances in the field."
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.